EKSO Q1 2023 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q1 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4M+60.6% YoY

Gross Profit

$2M48.5% margin

Operating Income

-$4M-107.9% margin

Net Income

-$4M-106.5% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

+16.1%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$517,000

Balance Sheet

Total Assets

$37M

Total Liabilities

$16M

Stockholders' Equity

$21M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+60.6%
Gross Profit	$2M	$1M	+65.4%
Operating Income	-$4M	-$4M	-5.0%
Net Income	-$4M	-$5M	+5.0%

Revenue Segments

EksoHealth

$4M97%

EksoWorks

$125,0003%

Geographic Segments

Americas

$3M36%

UNITED STATES

$3M36%

EMEA

$756,0009%

EMEA, Other

$512,0006%

Asia Pacific

$404,0005%

APAC, Other

$404,0005%

GERMANY

$244,0003%

Americas, Other

$4,0000%